Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
about
Nanotoxicology - a pathologist's perspectiveTitanium dioxide nanoparticles: a review of current toxicological dataToxicology of nanomaterials used in nanomedicineHuman health implications of nanomaterial exposureDispersion method for safety research on manufactured nanomaterialsApplications of nanotechnology in dermatologyNanosizing of drugs: Effect on dissolution rateActivation of neutrophils by nanoparticlesAdvances in aluminum hydroxide-based adjuvant research and its mechanismDevelopment of Taiwan's strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerationsToxicity of nanomaterialsMolecular mechanism of DNA damage induced by titanium dioxide nanoparticles in toll-like receptor 3 or 4 expressing human hepatocarcinoma cell linesComparison of the behaviour of manufactured and other airborne nanoparticles and the consequences for prioritising research and regulation activitiesRecent advances in particulate matter and nanoparticle toxicology: a review of the in vivo and in vitro studiesConvergence of nanotechnology and cancer prevention: are we there yet?Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancerNanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Principal component and causal analysis of structural and acute in vitro toxicity data for nanoparticles.Iron nanoparticles increase 7-ketocholesterol-induced cell death, inflammation, and oxidation on murine cardiac HL1-NB cells.Hierarchical Rank Aggregation with Applications to Nanotoxicology.In vivo effect of industrial titanium dioxide nanoparticles experimentally exposed to hairless rat skin.Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermiaAttenuation of allergic airway inflammation and hyperresponsiveness in a murine model of asthma by silver nanoparticles.Nanomedicine--challenge and perspectives.Carbon nanodots interference with lactate dehydrogenase assay in human monocyte THP-1 cellsDelivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids.Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cellsNanoparticles for applications in cellular imaging.Cutaneous exposure to agglomerates of silica nanoparticles and allergen results in IgE-biased immune response and increased sensitivity to anaphylaxis in mice.Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation.Exposure to Palladium Nanoparticles Affects Serum Levels of Cytokines in Female Wistar Rats.Silica nanoparticles induce reversible damage of spermatogenic cells via RIPK1 signal pathways in C57 mice.Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions.Nanoparticle-induced pulmonary toxicity.Nanotoxicology: an interdisciplinary challenge.Toxico-/biokinetics of nanomaterials.Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways.Fourier-transform infrared spectroscopy for rapid screening and live-cell monitoring: application to nanotoxicology.CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug products.Assessing nanoparticle risk poses prodigious challenges.
P2860
Q23909944-2142FCFA-24A2-4C50-991C-7C21CCC395A1Q23913609-A04A2E78-8260-4BE9-BDD7-A62C98367F9FQ23914977-0C99CCEB-04AA-4B46-A907-572CFE7C2979Q23922473-DECDABD3-73BC-40A8-A816-16F182D16716Q23923626-D6022E1F-F15D-42AF-AB42-86A3B26375A6Q24170384-E17B2926-790B-4650-892D-39CB9DAAA66AQ26781058-DBBBFA99-2ABC-4976-924E-4F8F1C1224EDQ26995680-77225A39-5161-426B-BDA9-E934A67EF530Q27007659-343455B9-FBEA-4B06-83D6-879AEFD5350BQ27687656-4C71A72E-9061-4856-A327-B9ACBAE91732Q28383168-621E19A3-AD0A-4A77-A07B-548C6199FE03Q28383875-CB0E59C8-E749-4A8C-9EF4-DC2D982799EDQ28384705-33FF9561-9145-438C-9911-21959B2232F3Q28385376-AB23D916-A1F5-4B43-82F9-836AD22DDA56Q28386699-4666E743-083F-480E-8B88-BE76FEBCE7E3Q29248491-585164E4-1928-48D0-81A6-3C80777E6808Q30387307-EA41377A-8A51-4F3F-B614-5DC2DE6FFE04Q30616632-9D304A11-26CC-45CA-B47E-F74E3957671CQ33576888-270F1D38-3304-48A6-B79B-DBF547501378Q33621840-4D6417AD-2566-483A-8183-7C27359EF9E2Q33675325-C6E0C785-CD7C-4967-9C21-151F3E5F887CQ33862718-DDC71EC2-CA24-4513-9728-2B26D513F472Q34177556-92BB0DC1-09DB-4B17-923B-39446B38B3E7Q34247073-91B1EF3E-F44C-4368-98E1-091F10947A5EQ34422373-DF0FB998-E739-46F6-9EEC-0869FF04699EQ35410974-CFAAFCD0-C5AF-4F59-ACA0-8C7DD5F151CEQ35489449-3D5ABAB5-FCB0-46F2-BEF3-4880C715E41FQ35635842-6E9279A9-D96E-478E-BC80-2CE91AC7FD24Q35786805-D7F1EB8E-3F41-4020-99AB-C67155E18092Q35846840-72C9AC96-8E9C-49FC-AF7A-63CE3AFB017CQ35855610-12FA4516-D7F2-4168-9653-28C6E1CE52F1Q36951459-DC6AE4EE-B45F-4788-9FDB-6F8E351722FDQ37668353-E12091B8-C1F5-4AD2-A5FD-634C467C78DEQ37780881-A8BB3B6C-4F52-4BA1-B1A2-28DF4F93C552Q37835204-AD9F06B5-0FA4-4284-9310-3EE9CB8CB115Q38009230-B3972A62-55DF-4FEE-AB8E-1162BC567BB2Q38053080-95EA62F9-9F1E-4DD3-B601-359728E0F1AFQ38068917-601D498A-4178-4D09-8CE6-CBABF8D281C6Q38091386-BCF96562-159E-48BF-967A-303B7BF985D6Q38097389-D325100F-30EE-464A-92D5-D06AF64F1A0F
P2860
Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Research strategies for safety ...... k assessment of nanoparticles.
@ast
Research strategies for safety ...... k assessment of nanoparticles.
@en
Research strategies for safety ...... k assessment of nanoparticles.
@nl
type
label
Research strategies for safety ...... k assessment of nanoparticles.
@ast
Research strategies for safety ...... k assessment of nanoparticles.
@en
Research strategies for safety ...... k assessment of nanoparticles.
@nl
prefLabel
Research strategies for safety ...... k assessment of nanoparticles.
@ast
Research strategies for safety ...... k assessment of nanoparticles.
@en
Research strategies for safety ...... k assessment of nanoparticles.
@nl
P2093
P2860
P356
P1476
Research strategies for safety ...... k assessment of nanoparticles.
@en
P2093
Andrew D Maynard
Annette B Santamaria
Chiu-Wing Lam
David B Warheit
John T James
Joyce S Tsuji
Paul C Howard
P2860
P356
10.1093/TOXSCI/KFI339
P577
2005-09-21T00:00:00Z